BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6220750)

  • 21. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
    Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
    Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
    APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC; Nimmo JC; Hart DN
    Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
    Yanagawa E; Uchida A; Micksche M
    Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
    Fukui H; Overton WR; Herberman RB; Reynolds CW
    J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
    J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
    Demeter J; Pálóczi K; Lehoczky D; Benczúr M
    Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
    Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
    Werkmeister JA; Boyd AW; Triglia T; Burns GF
    Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.
    Klimpel GR; Herndon DH; Stein MD
    J Clin Immunol; 1988 Jan; 8(1):14-22. PubMed ID: 2966807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of human spleen interferon on natural killer activity of peripheral blood lymphocytes enriched in large granular lymphocytes.
    Launay M; Genetet B; Ruffault A; Fauconnier B
    Immunol Lett; 1982; 5(6):345-50. PubMed ID: 6984689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM-1+ spleen hairy cells.
    Ruco LP; Stoppacciaro A; Valtieri M; Procopio A; Uccini S; Baroni CD
    Clin Immunol Immunopathol; 1983 Jan; 26(1):47-55. PubMed ID: 6603305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hairy-cells are not lysed by NK-cells.
    Sigaux F; Chapuis F; Castaigne S; Degos L; Flandrin G; Gluckman JC
    Blut; 1987 May; 54(5):319-20. PubMed ID: 3567370
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
    Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.